May 17, 2023 / 11:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Q4 and FY '23 Earnings Conference Call of Eris Lifesciences Limited.
We have with us on the call today Mr. Amit Bakshi, Chairman and Managing Director; and Mr. V. Krishnakumar, Chief Operating Officer and Executive Director.
(Operator Instructions)
Please note that this conference is being recorded. I now hand the conference over to Mr. V. Krishnakumar, Chief Operating Officer and Executive Director of the company.
Thank you, and over to you, sir.
Krishnakumar Vaidyanathan - Eris Lifesciences Limited - Executive Director & COO
Thank you. Good afternoon, and welcome to our fourth quarter conference call. I'm Krishnakumar, and I'll be sharing the highlights of the quarter and full year review. We have reported stand-alone revenues of INR 315 crores in quarter 4 which represents a growth of 11.5%. Our stand-alone revenue for FY '23 stands at INR 1,331 crores, which represents a growth of 9.5%. This has been lower than our guidance due to a couple of factors.
Q4 2023 Eris Lifesciences Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot